European registry of babies born to mothers with antiphospholipid syndrome

A result update

Marie Claire Boffa, E. Lachassinne, C. Boinot, S. De Carolis, P. Rovere-Querini, T. Avcin, C. Biasini-Rebaioli, P. Le Toumelin, M. H. Aurousseau, A. Tincani

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The registry is a prospective, European, multicentric, longitudinal study, which follows a cohort of children born to mothers with antiphospholipid syndrome (APS). It was started in 2003. In this report, we update the results obtained from the study of 110 mothers and 112 children (two twin births). Eighty per cent of the mothers (n = 86) had primary APS. Purely obstetrical, thrombotic and mixed (obstetrical and thrombotic) APS represent 65.5 %, 21.8 % and 12.7 % of the whole cohort respectively. Isolated antiphospholipid antibodies and isolated anticardiolipin antibodies positivity were present in 50 of 109 (46%) and in 34 of 109 (31%) of the pregnant women, respectively. In the babies, in spite of a high rate of prematurity (14.3%) with four (3.6%) of the premature babies born before 33 weeks of gestation and an increased number of newborns small for gestational age (17%), the large majority of the neonates were healthy. Thirty-one infants are now older than 24 months. Among them, three displayed behavioural abnormalities before 3 years of age. After completing data, there will be the possibility to evaluate the newborn status in relation to the mothers' diseases, treatments and antibodies and to follow the neuropsychological development and immunological evolution of the babies during the next 5 years.

Original languageEnglish
Pages (from-to)900-904
Number of pages5
JournalLupus
Volume18
Issue number10
DOIs
Publication statusPublished - 2009

Fingerprint

Antiphospholipid Syndrome
Registries
Mothers
Newborn Infant
Anticardiolipin Antibodies
Antiphospholipid Antibodies
Gestational Age
Longitudinal Studies
Pregnant Women
Parturition
Pregnancy
Antibodies
Therapeutics

Keywords

  • Abnormal neuropsychological development
  • Anti-beta;- glycoprotein 1 antibodies
  • Anticardiolipin antibodies
  • Antiphospholipid antibodies
  • Antiphospholipid syndrome
  • Newborn
  • Thrombosis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Boffa, M. C., Lachassinne, E., Boinot, C., De Carolis, S., Rovere-Querini, P., Avcin, T., ... Tincani, A. (2009). European registry of babies born to mothers with antiphospholipid syndrome: A result update. Lupus, 18(10), 900-904. https://doi.org/10.1177/0961203309106951

European registry of babies born to mothers with antiphospholipid syndrome : A result update. / Boffa, Marie Claire; Lachassinne, E.; Boinot, C.; De Carolis, S.; Rovere-Querini, P.; Avcin, T.; Biasini-Rebaioli, C.; Le Toumelin, P.; Aurousseau, M. H.; Tincani, A.

In: Lupus, Vol. 18, No. 10, 2009, p. 900-904.

Research output: Contribution to journalArticle

Boffa, MC, Lachassinne, E, Boinot, C, De Carolis, S, Rovere-Querini, P, Avcin, T, Biasini-Rebaioli, C, Le Toumelin, P, Aurousseau, MH & Tincani, A 2009, 'European registry of babies born to mothers with antiphospholipid syndrome: A result update', Lupus, vol. 18, no. 10, pp. 900-904. https://doi.org/10.1177/0961203309106951
Boffa, Marie Claire ; Lachassinne, E. ; Boinot, C. ; De Carolis, S. ; Rovere-Querini, P. ; Avcin, T. ; Biasini-Rebaioli, C. ; Le Toumelin, P. ; Aurousseau, M. H. ; Tincani, A. / European registry of babies born to mothers with antiphospholipid syndrome : A result update. In: Lupus. 2009 ; Vol. 18, No. 10. pp. 900-904.
@article{746536bd1cc94efb81c4ce7f98558519,
title = "European registry of babies born to mothers with antiphospholipid syndrome: A result update",
abstract = "The registry is a prospective, European, multicentric, longitudinal study, which follows a cohort of children born to mothers with antiphospholipid syndrome (APS). It was started in 2003. In this report, we update the results obtained from the study of 110 mothers and 112 children (two twin births). Eighty per cent of the mothers (n = 86) had primary APS. Purely obstetrical, thrombotic and mixed (obstetrical and thrombotic) APS represent 65.5 {\%}, 21.8 {\%} and 12.7 {\%} of the whole cohort respectively. Isolated antiphospholipid antibodies and isolated anticardiolipin antibodies positivity were present in 50 of 109 (46{\%}) and in 34 of 109 (31{\%}) of the pregnant women, respectively. In the babies, in spite of a high rate of prematurity (14.3{\%}) with four (3.6{\%}) of the premature babies born before 33 weeks of gestation and an increased number of newborns small for gestational age (17{\%}), the large majority of the neonates were healthy. Thirty-one infants are now older than 24 months. Among them, three displayed behavioural abnormalities before 3 years of age. After completing data, there will be the possibility to evaluate the newborn status in relation to the mothers' diseases, treatments and antibodies and to follow the neuropsychological development and immunological evolution of the babies during the next 5 years.",
keywords = "Abnormal neuropsychological development, Anti-beta;- glycoprotein 1 antibodies, Anticardiolipin antibodies, Antiphospholipid antibodies, Antiphospholipid syndrome, Newborn, Thrombosis",
author = "Boffa, {Marie Claire} and E. Lachassinne and C. Boinot and {De Carolis}, S. and P. Rovere-Querini and T. Avcin and C. Biasini-Rebaioli and {Le Toumelin}, P. and Aurousseau, {M. H.} and A. Tincani",
year = "2009",
doi = "10.1177/0961203309106951",
language = "English",
volume = "18",
pages = "900--904",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "10",

}

TY - JOUR

T1 - European registry of babies born to mothers with antiphospholipid syndrome

T2 - A result update

AU - Boffa, Marie Claire

AU - Lachassinne, E.

AU - Boinot, C.

AU - De Carolis, S.

AU - Rovere-Querini, P.

AU - Avcin, T.

AU - Biasini-Rebaioli, C.

AU - Le Toumelin, P.

AU - Aurousseau, M. H.

AU - Tincani, A.

PY - 2009

Y1 - 2009

N2 - The registry is a prospective, European, multicentric, longitudinal study, which follows a cohort of children born to mothers with antiphospholipid syndrome (APS). It was started in 2003. In this report, we update the results obtained from the study of 110 mothers and 112 children (two twin births). Eighty per cent of the mothers (n = 86) had primary APS. Purely obstetrical, thrombotic and mixed (obstetrical and thrombotic) APS represent 65.5 %, 21.8 % and 12.7 % of the whole cohort respectively. Isolated antiphospholipid antibodies and isolated anticardiolipin antibodies positivity were present in 50 of 109 (46%) and in 34 of 109 (31%) of the pregnant women, respectively. In the babies, in spite of a high rate of prematurity (14.3%) with four (3.6%) of the premature babies born before 33 weeks of gestation and an increased number of newborns small for gestational age (17%), the large majority of the neonates were healthy. Thirty-one infants are now older than 24 months. Among them, three displayed behavioural abnormalities before 3 years of age. After completing data, there will be the possibility to evaluate the newborn status in relation to the mothers' diseases, treatments and antibodies and to follow the neuropsychological development and immunological evolution of the babies during the next 5 years.

AB - The registry is a prospective, European, multicentric, longitudinal study, which follows a cohort of children born to mothers with antiphospholipid syndrome (APS). It was started in 2003. In this report, we update the results obtained from the study of 110 mothers and 112 children (two twin births). Eighty per cent of the mothers (n = 86) had primary APS. Purely obstetrical, thrombotic and mixed (obstetrical and thrombotic) APS represent 65.5 %, 21.8 % and 12.7 % of the whole cohort respectively. Isolated antiphospholipid antibodies and isolated anticardiolipin antibodies positivity were present in 50 of 109 (46%) and in 34 of 109 (31%) of the pregnant women, respectively. In the babies, in spite of a high rate of prematurity (14.3%) with four (3.6%) of the premature babies born before 33 weeks of gestation and an increased number of newborns small for gestational age (17%), the large majority of the neonates were healthy. Thirty-one infants are now older than 24 months. Among them, three displayed behavioural abnormalities before 3 years of age. After completing data, there will be the possibility to evaluate the newborn status in relation to the mothers' diseases, treatments and antibodies and to follow the neuropsychological development and immunological evolution of the babies during the next 5 years.

KW - Abnormal neuropsychological development

KW - Anti-beta;- glycoprotein 1 antibodies

KW - Anticardiolipin antibodies

KW - Antiphospholipid antibodies

KW - Antiphospholipid syndrome

KW - Newborn

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=68949175634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949175634&partnerID=8YFLogxK

U2 - 10.1177/0961203309106951

DO - 10.1177/0961203309106951

M3 - Article

VL - 18

SP - 900

EP - 904

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 10

ER -